{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T11:12:14Z","timestamp":1740136334281,"version":"3.37.3"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2018,12,12]],"date-time":"2018-12-12T00:00:00Z","timestamp":1544572800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100002426","name":"Fondazione Telethon","doi-asserted-by":"publisher","award":["GEP12083"],"award-info":[{"award-number":["GEP12083"]}],"id":[{"id":"10.13039\/501100002426","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol Sci"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1007\/s10072-018-3645-2","type":"journal-article","created":{"date-parts":[[2018,12,12]],"date-time":"2018-12-12T05:27:59Z","timestamp":1544592479000},"page":"503-507","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Clinical and genetic characterization of an Italian family with slow-channel syndrome"],"prefix":"10.1007","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9554-8794","authenticated-orcid":false,"given":"Corrado","family":"Angelini","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ludovico","family":"Lispi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cecilia","family":"Salvoro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Luisa","family":"Mostacciuolo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanni","family":"Vazza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,12,12]]},"reference":[{"key":"3645_CR1","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1097\/WCO.0000000000000370","volume":"29","author":"D Beeson","year":"2016","unstructured":"Beeson D (2016) Congenital myasthenic syndromes: recent advances. Curr Opin Neurol 29:565\u2013571. \n                              https:\/\/doi.org\/10.1097\/WCO.0000000000000370","journal-title":"Curr Opin Neurol"},{"key":"3645_CR2","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.1002\/humu.22130","volume":"33","author":"A Abicht","year":"2012","unstructured":"Abicht A, Dusl M, Gallenm\u00fcller C, Guergueltcheva V, Schara U, Della Marina A, Wibbeler E, Almaras S, Mihaylova V, von der Hagen M, Huebner A, Chaouch A, M\u00fcller JS, Lochm\u00fcller H (2012) Congenital myasthenic syndromes: achievements and limitations of phenotype-guided gene-after-gene sequencing in diagnostic practice: a study of 680 patients. Hum Mutat 33:1474\u20131484. \n                              https:\/\/doi.org\/10.1002\/humu.22130","journal-title":"Hum Mutat"},{"key":"3645_CR3","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1002\/ana.410110603","volume":"11","author":"AG Engel","year":"1982","unstructured":"Engel AG, Lambert EH, Mulder DM, Torres CF, Sahashi K, Bertorini TE, Whitaker JN (1982) A newly recognized congenital myasthenic syndrome attributed to a prolonged open time of the acetylcholine-induced ion channel. Ann Neurol 11:553\u2013569. \n                              https:\/\/doi.org\/10.1002\/ana.410110603","journal-title":"Ann Neurol"},{"key":"3645_CR4","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1212\/WNL.59.2.162","volume":"59","author":"R Croxen","year":"2002","unstructured":"Croxen R, Hatton C, Shelley C, Brydson M, Chauplannaz G, Oosterhuis H, Vincent A, Newsom-Davis J, Colquhoun D, Beeson D (2002) Recessive inheritance and variable penetrance of slow-channel congenital myasthenic syndromes. Neurology 59:162\u2013168. \n                              https:\/\/doi.org\/10.1212\/WNL.59.2.162","journal-title":"Neurology"},{"key":"3645_CR5","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.jbior.2015.11.010","volume":"61","author":"J Ghim","year":"2016","unstructured":"Ghim J, Chelakkot C, Bae Y-S, Ryu SH (2016) Accumulating insights into the role of phospholipase D2 in human diseases. Adv Biol Regul 61:42\u201346. \n                              https:\/\/doi.org\/10.1016\/J.JBIOR.2015.11.010","journal-title":"Adv Biol Regul"},{"key":"3645_CR6","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1002\/ana.23831","volume":"73","author":"P Hackman","year":"2013","unstructured":"Hackman P, Sarparanta J, Lehtinen S, Vihola A, Evil\u00e4 A, Jonson PH, Luque H, Kere J, Screen M, Chinnery PF, \u00c5hlberg G, Edstr\u00f6m L, Udd B (2013) Welander distal myopathy is caused by a mutation in the RNA-binding protein TIA1. Ann Neurol 73:500\u2013509. \n                              https:\/\/doi.org\/10.1002\/ana.23831","journal-title":"Ann Neurol"},{"key":"3645_CR7","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.nmd.2007.01.010","volume":"17","author":"E Pegoraro","year":"2007","unstructured":"Pegoraro E, Gavassini BF, Borsato C, Melacini P, Vianello A, Stramare R, Cenacchi G, Angelini C (2007) MYH7 gene mutation in myosin storage myopathy and scapulo-peroneal myopathy. Neuromuscul Disord 17:321\u2013329. \n                              https:\/\/doi.org\/10.1016\/j.nmd.2007.01.010","journal-title":"Neuromuscul Disord"},{"key":"3645_CR8","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/0022-510X(81)90067-8","volume":"51","author":"I Nonaka","year":"1981","unstructured":"Nonaka I, Sunohara N, Ishiura S, Satoyoshi E (1981) Familial distal myopathy with rimmed vacuole and lamellar (myeloid) body formation. J Neurol Sci 51:141\u2013155. \n                              https:\/\/doi.org\/10.1016\/0022-510X(81)90067-8","journal-title":"J Neurol Sci"},{"issue":"Pt 4","key":"3645_CR9","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1093\/brain\/110.4.1061","volume":"110","author":"HJ Oosterhuis","year":"1987","unstructured":"Oosterhuis HJ, Newsom-Davis J, Wokke JH et al (1987) The slow channel syndrome. Two new cases. Brain 110(Pt 4):1061\u20131079","journal-title":"Brain"},{"key":"3645_CR10","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.nmd.2006.02.009","volume":"16","author":"J Colomer","year":"2006","unstructured":"Colomer J, M\u00fcller JS, Vernet A, Nascimento A, Pons M, Gonzalez V, Abicht A, Lochm\u00fcller H (2006) Long-term improvement of slow-channel congenital myasthenic syndrome with fluoxetine. Neuromuscul Disord 16:329\u2013333. \n                              https:\/\/doi.org\/10.1016\/j.nmd.2006.02.009","journal-title":"Neuromuscul Disord"},{"key":"3645_CR11","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1093\/hmg\/ddt397","volume":"23","author":"H Zhu","year":"2014","unstructured":"Zhu H, Pytel P, Gomez CM (2014) Selective inhibition of caspases in skeletal muscle reverses the apoptotic synaptic degeneration in slow-channel myasthenic syndrome. Hum Mol Genet 23:69\u201377. \n                              https:\/\/doi.org\/10.1093\/hmg\/ddt397","journal-title":"Hum Mol Genet"},{"key":"3645_CR12","doi-asserted-by":"crossref","unstructured":"Engel AG, Ohno K, Milone M, Wang HL, Nakano S, Bouzat C, Pruitt JN 2nd, Hutchinson DO, Brengman JM, Bren N, Sieb JP, Sine SM (1996) New mutations in acetylcholine receptor subunit genes reveal heterogeneity in the slow-channel congenital myasthenic syndrome. Hum Mol Genet 5:1217\u20131227","DOI":"10.1093\/hmg\/5.9.1217"},{"key":"3645_CR13","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1113\/jphysiol.2002.034173","volume":"547","author":"CJ Hatton","year":"2003","unstructured":"Hatton CJ, Shelley C, Brydson M, Beeson D, Colquhoun D (2003) Properties of the human muscle nicotinic receptor, and of the slow-channel myasthenic syndrome mutant epsilonL221F, inferred from maximum likelihood fits. J Physiol 547:729\u2013760. \n                              https:\/\/doi.org\/10.1113\/jphysiol.2002.034173","journal-title":"J Physiol"},{"key":"3645_CR14","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1007\/s12031-009-9229-0","volume":"40","author":"AG Engel","year":"2010","unstructured":"Engel AG, Shen X-M, Selcen D, Sine SM (2010) What have we learned from the congenital myasthenic syndromes. J Mol Neurosci 40:143\u2013153. \n                              https:\/\/doi.org\/10.1007\/s12031-009-9229-0","journal-title":"J Mol Neurosci"},{"key":"3645_CR15","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1016\/j.nbd.2011.10.024","volume":"45","author":"F Chevessier","year":"2012","unstructured":"Chevessier F, Peter C, Mersdorf U, Girard E, Krejci E, McArdle JJ, Witzemann V (2012) A new mouse model for the slow-channel congenital myasthenic syndrome induced by the AChR \u03b5L221F mutation. Neurobiol Dis 45:851\u2013861. \n                              https:\/\/doi.org\/10.1016\/j.nbd.2011.10.024","journal-title":"Neurobiol Dis"},{"key":"3645_CR16","doi-asserted-by":"publisher","first-page":"1710","DOI":"10.1212\/01.WNL.0000061483.11417.1B","volume":"60","author":"CM Harper","year":"2003","unstructured":"Harper CM, Fukodome T, Engel AG (2003) Treatment of slow-channel congenital myasthenic syndrome with fluoxetine. Neurology 60:1710\u20131713","journal-title":"Neurology"}],"container-title":["Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-018-3645-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10072-018-3645-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-018-3645-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,12,11]],"date-time":"2019-12-11T19:15:29Z","timestamp":1576091729000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10072-018-3645-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12,12]]},"references-count":16,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,3]]}},"alternative-id":["3645"],"URL":"https:\/\/doi.org\/10.1007\/s10072-018-3645-2","relation":{},"ISSN":["1590-1874","1590-3478"],"issn-type":[{"type":"print","value":"1590-1874"},{"type":"electronic","value":"1590-3478"}],"subject":[],"published":{"date-parts":[[2018,12,12]]},"assertion":[{"value":"15 May 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 November 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 December 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}